NDC 71351-022 – Bupivacaine Hydrochloride

Bupivacaine Hydrochloride 7.5 mg/mL · Injection · Subarachnoid

Human Prescription Drug 1 recall

Product NDC71351-022

Product details

Brand name
Bupivacaine Hydrochloride
Generic name
Bupivacaine hydrochloride
Labeler
Brookfield Pharmaceuticals, LLC.
Dosage form
Injection
Route
Subarachnoid
Marketing category
ANDA · ANDA212822
Marketed since
October 31, 2022
Listing expires
December 31, 2027
Pharmacologic class
Amide Local Anesthetic

Active ingredients

Uses, dosage, side effects and warnings for Bupivacaine Hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
71351-022-1010 AMPULE in 1 PACKAGE (71351-022-10) / 2 mL in 1 AMPULE (71351-022-02)Feb 23, 2023
71351-022-5050 AMPULE in 1 PACKAGE (71351-022-50) / 2 mL in 1 AMPULE (71351-022-02)Oct 31, 2022

Recalls mentioning this NDC

Other Bupivacaine Hydrochloride products